Search Results - "Lu, Chris X."

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    TRAF4 Promotes TGF-β Receptor Signaling and Drives Breast Cancer Metastasis by Zhang, Long, Zhou, Fangfang, García de Vinuesa, Amaya, de Kruijf, Esther M., Mesker, Wilma E., Hui, Li, Drabsch, Yvette, Li, Yihao, Bauer, Andreas, Rousseau, Adrien, Sheppard, Kelly-Ann, Mickanin, Craig, Kuppen, Peter J.K., Lu, Chris X., ten Dijke, Peter

    Published in Molecular cell (12-09-2013)
    “…TGF-β signaling is a therapeutic target in advanced cancers. We identified tumor necrosis factor receptor-associated factor 4 (TRAF4) as a key component…”
    Get full text
    Journal Article
  2. 2

    USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor by Zhang, Long, Zhou, FangFang, Drabsch, Yvette, Gao, Rui, Snaar-Jagalska, B. Ewa, Mickanin, Craig, Huang, Huizhe, Sheppard, Kelly-Ann, Porter, Jeff A., Lu, Chris X., ten Dijke, Peter

    Published in Nature cell biology (01-07-2012)
    “…The stability and membrane localization of the transforming growth factor-β (TGF-β) type I receptor (TβRI) determines the levels of TGF-β signalling. TβRI is…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Fine-tuning BMP7 signalling in adipogenesis by UBE2O/E2-230K-mediated monoubiquitination of SMAD6 by Zhang, Xiaofei, Zhang, Juan, Bauer, Andreas, Zhang, Long, Selinger, Douglas W, Lu, Chris X, ten Dijke, Peter

    Published in The EMBO journal (03-04-2013)
    “…SMAD6 is a crucial feedback inhibitory regulator of bone morphogenetic protein (BMP)/SMAD signalling. Although little is known regarding the…”
    Get full text
    Journal Article
  8. 8

    An effective AKT inhibitor-PARP inhibitor combination therapy for recurrent ovarian cancer by Xu, Jing, Gao, Yi, Luan, Xiaotian, Li, Ke, Wang, Jing, Dai, Yilin, Kang, Mingyi, Lu, Chong, Zhang, Minhua, Lu, Chris X., Kang, Yu, Xu, Congjian

    Published in Cancer chemotherapy and pharmacology (01-05-2022)
    “…Background Although the use of PARP inhibitor has received considerable amount of attention in ovarian cancer, PARP inhibitor resistance still emerges with…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-[beta] type I receptor by Zhang, Long, Zhou, Fangfang, Drabsch, Yvette, Gao, Rui, Snaar-jagalska, B Ewa, Mickanin, Craig, Huang, Huizhe, Sheppard, Kelly-ann, Porter, Jeff A, Lu, Chris X, Ten Dijke, Peter

    Published in Nature cell biology (01-07-2012)
    “…The stability and membrane localization of the transforming growth factor-[beta] (TGF-[beta]) type I receptor (T[beta]RI) determines the levels of TGF-[beta]…”
    Get full text
    Journal Article
  13. 13